Dividends & Buybacks ·
DataMEDS AI repurchases 364,099 shares for $350K and settles litigation, extinguishing $19M in liability
MEDSDataMeds AI, Inc.
DataMEDS AI, Inc. entered into a settlement agreement with former sellers to resolve disputes regarding the Membership Interest Purchase Agreement. The company paid $450,000 total: $350,000 was allocated to repurchase and extinguish 364,099 shares of common stock, while $100,000 settled all other released claims. This transaction resulted in the extinguishment of approximately $19 million in liabilities on the consolidated balance sheet and increased stockholders' equity above $2.5 million. Additionally, the company licensed a care management platform from REBOOT Health AI, Inc., issuing 666,667 shares as consideration. DataMEDS AI operates in the healthcare technology sector, providing AI-driven solutions for medication adherence and patient engagement.